Mesenchymal stromal cell-derived extracellular vesicles reduce lung inflammation and damage in nonclinical acute lung injury: Implications for COVID-19.
Mesenchymal stem cell derived extracellular vesicles (MSC-EVs) are bioactive particles that evoke beneficial responses in recipient cells. We identified a role for MSC-EV in immune modulation and cellular salvage in a model of SARS-CoV-2 induced acute lung injury (ALI) using pulmonary epithelial cel...
Main Authors: | Caryn Cloer, Laila Roudsari, Lauren Rochelle, Timothy Petrie, Michaela Welch, Joseph Charest, Kelly Tan, Li Fugang, Thomas Petersen, Roger Ilagan, Sarah Hogan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0259732 |
Similar Items
-
Mesenchymal stromal cell-derived extracellular vesicles reduce lung inflammation and damage in nonclinical acute lung injury: Implications for COVID-19
by: Caryn Cloer, et al.
Published: (2021-01-01) -
Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives
by: Soraia C. Abreu, et al.
Published: (2021-02-01) -
Biodistribution of mesenchymal stromal cell-derived extracellular vesicles administered during acute lung injury
by: Alvin Tieu, et al.
Published: (2023-09-01) -
Influence of Extracellular Vesicles on Lung Stromal Cells during Breast Cancer Metastasis
by: Urvi Patel, et al.
Published: (2023-07-01) -
Extracellular Vesicle Mediated Tumor-Stromal Crosstalk Within an Engineered Lung Cancer Model
by: Kayla F. Goliwas, et al.
Published: (2021-04-01)